A clinical trial to study the effectiveness of CI-578 in the treatment of ascaris and/or oxyuris infections

Both CI-578 suspension and CI-578 lozenges appear to be effective in eliminating ascaris and oxyuris infections although the lozenges were slightly better than the suspension for the elimination of oxyuris infections. Although a larger number of different types of symptoms were reported in the lozenge group, there was little difference between treatment groups in either frequency of occurrence of symptoms or severity of symptoms. Symptoms due to the drugs in both treatment groups had disappeared by day 7 (AU)